{"nct_id":"NCT02345226","title":"Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIV-1 Infected Adults","status":"COMPLETED","status_verified_date":"2019-12","start_date":"2015-01-26","start_date_type":"ACTUAL","primary_completion_date":"2016-06-29","primary_completion_date_type":"ACTUAL","completion_date":"2019-01-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}